Advanced materials for drug delivery across mucosal barriers.

Drug delivery Functional polymers Mucoadhesion Mucolytic agents Mucus penetration

Journal

Acta biomaterialia
ISSN: 1878-7568
Titre abrégé: Acta Biomater
Pays: England
ID NLM: 101233144

Informations de publication

Date de publication:
01 01 2021
Historique:
received: 29 07 2020
revised: 16 10 2020
accepted: 20 10 2020
pubmed: 4 11 2020
medline: 15 5 2021
entrez: 3 11 2020
Statut: ppublish

Résumé

Mucus is a viscoelastic gel that traps pathogens and other foreign particles to limit their penetration into the underlying epithelium. Dosage forms containing particle-based drug delivery systems are trapped in mucosal layers and will be removed by mucus turnover. Mucoadhesion avoids premature wash-off and prolongs the residence time of drugs on mucus. Moreover, mucus penetration is essential for molecules to access the underlying epithelial tissues. Various strategies have been investigated to achieve mucoadhesion and mucus penetration of drug carriers. Innovations in materials used for the construction of drug-carrier systems allowed the development of different mucoadhesion and mucus penetration delivery systems. Over the last decade, advances in the field of materials chemistry, with a focus on biocompatibility, have led to the expansion of the pool of materials available for drug delivery applications. The choice of materials in mucosal delivery is generally dependent on the intended therapeutic target and nature of the mucosa at the site of absorption. This review presents an up-to-date account of materials including synthesis, physical and chemical modifications of mucoadhesive materials, nanocarriers, viral mimics used for the construction of mucosal drug delivery systems.

Identifiants

pubmed: 33141051
pii: S1742-7061(20)30620-6
doi: 10.1016/j.actbio.2020.10.031
pii:
doi:

Substances chimiques

Drug Carriers 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

13-29

Informations de copyright

Copyright © 2020. Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors report no financial interest that might pose a potential, perceived or real conflict of interest.

Auteurs

Sony Priyanka Bandi (SP)

Department of Pharmacy, Birla Institute of Technology and Science (BITS) Pilani, Hyderabad Campus, Hyderabad 500078, Telangana State, India.

Shubhmita Bhatnagar (S)

School of Pharmacy, Temple University, Philadelphia PA 19140, USA.

Venkata Vamsi Krishna Venuganti (VVK)

Department of Pharmacy, Birla Institute of Technology and Science (BITS) Pilani, Hyderabad Campus, Hyderabad 500078, Telangana State, India. Electronic address: vamsi@hyderabad.bits-pilani.ac.in.

Articles similaires

Vancomycin Polyesters Anti-Bacterial Agents Models, Theoretical Drug Liberation

Folate-engineered chitosan nanoparticles: next-generation anticancer nanocarriers.

Prashant Kesharwani, Kratika Halwai, Saurav Kumar Jha et al.
1.00
Chitosan Humans Folic Acid Nanoparticles Drug Carriers
Nanoparticles Needles Polylactic Acid-Polyglycolic Acid Copolymer Polyethylene Glycols Curcumin
Administration, Intranasal Humans Animals Nasal Mucosa Brain

Classifications MeSH